Skip to content

Impact Assessment and indicator Development for Care Robots

Analysis of the physical impact of wearing of a soft-wearable robot and development of evaluation indicators

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011161
Enrollment
40
Registered
2025-11-13
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Twenty participants will be randomly assigned to each of the Usual-Robot Group and the Robot-Usual Group. The Usual-Robot Group will undergo 6 weeks of usual daily life without interv

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who are 65 years of age or older, or those with gait impairment requiring assistance without physical contact during walking (Functional Ambulation Category [FAC] grade 3–4). 2. Individuals capable of independently walking more than 10 meters without the use of a walking aid (ambulatory without an assistive device). 3. Individuals who are willing to participate in 6 weeks of robot-assisted gait intervention. 4. Individuals who are able to receive information about this study, provide written informed consent prior to participation, and comply with the requirements of the clinical trial.

Exclusion criteria

Exclusion criteria: 1. Individuals with medical conditions likely to worsen during study participation (e.g., uncontrolled hypertension [SBP =180 mmHg, DBP =110 mmHg], acute infectious diseases, etc.). 2. Individuals with severe heart failure or chronic obstructive pulmonary disease (COPD) presenting symptoms even during daily life, making walking difficult due to impaired cardiopulmonary function. 3. Individuals with musculoskeletal problems affecting physical function or motor ability (e.g., history of hip or knee arthroplasty, spinal fusion surgery within the past year). 4. Individuals with progressive neurological diseases characterized by rapid symptom deterioration (e.g., amyotrophic lateral sclerosis) that make it difficult to evaluate the effects of robot-assisted gait intervention. 5. Individuals unable to walk without assistance involving physical contact (FAC grade 1–2). 6. Individuals with skin disorders, severe spasticity, or other conditions that limit the use of a gait-assist robot 7. Individuals with reluctance or refusal to participate in robot-assisted gait training. 8. Individuals unable to understand the purpose of the clinical trial or to perform the study-related requirements. 9. Any other cases where the investigator judges that the individual’s condition makes participation in the study inappropriate.

Design outcomes

Primary

MeasureTime frame
SPPB (Short Physical Performance Battery)

Secondary

MeasureTime frame
x-ray(whole spine AP/lat, teleradiogram);Modified Nordic Musculoskeletal Questionairre;MOCA, PHQ-9, EQ-5D;Hand grip strength and lower extremity muscle strength;Bioelectrical Impedance Analysis;Dual-Energy X-ray Absorptiometry;Timed Up and Go Test;6 minute walk test;K-Physical Activity Scale for the Elderly;Daily step count;Korean Modified Barthel Index;Provocation test (if positive after screening, additional tests will be conducted);passive range of motion, assisted range of motion;Telephone follow-up survey (falls, pain, discomfort while wearing, usability);user log (by WIM application)

Countries

Korea, Republic of

Contacts

Public ContactMINWOO HONG

Seoul National University Hospital

kor17105@gmail.com+82-2-2072-3940

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026